Publicaciones en colaboración con investigadores/as de Hospital Ramón y Cajal (19)

2024

  1. Subclinical synovitis impact on the progression of lupus joint disease: A 10-year longitudinal multicenter study

    Lupus, Vol. 33, Núm. 6, pp. 638-643

2023

  1. Epidemiology and clinical characteristics of psoriatic arthritis-related uveitis in Madrid, Spain

    International Ophthalmology, Vol. 43, Núm. 3, pp. 771-777

  2. HLA-Cw6 allele and biologic therapy are protective factors against liver fibrosis in psoriatic arthritis patients

    Clinical and Experimental Rheumatology, Vol. 41, Núm. 5, pp. 1179-1182

2022

  1. VIP/VPAC Axis Expression in Immune-Mediated Inflammatory Disorders: Associated miRNA Signatures

    International journal of molecular sciences, Vol. 23, Núm. 15

2021

  1. Ellipsoid layer restoration after Ozurdex® treatment in a patient with acute posterior multifocal placoid pigment epitheliopathy

    European Journal of Ophthalmology, Vol. 31, Núm. 2, pp. NP49-NP53

  2. Risk of severe COVID-19 infection in patients with inflammatory rheumatic diseases

    Journal of Rheumatology, Vol. 48, Núm. 7, pp. 1098-1102

  3. Tocilizumab in refractory giant cell arteritis. Monotherapy versus combined therapy with conventional immunosuppressive drugs. Observational multicenter study of 134 patients

    Seminars in Arthritis and Rheumatism, Vol. 51, Núm. 2, pp. 387-394

2020

  1. Anti-il-6 receptor tocilizumab in refractory graves’ orbitopathy: National multicenter observational study of 48 patients

    Journal of Clinical Medicine, Vol. 9, Núm. 9, pp. 1-15

  2. Do Season and Environment Have a Role in the Incidence of Anterior Uveitis Attacks?

    Ocular Immunology and Inflammation, Vol. 28, Núm. 5, pp. 786-790

  3. Prevalence of subclinical synovitis of the hand in patients with systemic lupus erythematosus

    Lupus, Vol. 29, Núm. 11, pp. 1423-1429

  4. Tocilizumab in giant cell arteritis: differences between the GiACTA trial and a multicentre series of patients from the clinical practice

    Clinical and experimental rheumatology, Vol. 38, Núm. 2, pp. 112-119

2019

  1. Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice

    Seminars in Arthritis and Rheumatism, Vol. 49, Núm. 1, pp. 126-135

2018

  1. Efficacy of Tocilizumab in Patients With Moderate-to-Severe Corticosteroid-Resistant Graves Orbitopathy: A Randomized Clinical Trial

    American Journal of Ophthalmology, Vol. 195, pp. 181-190

  2. Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's Disease

    Ophthalmology, Vol. 125, Núm. 9, pp. 1444-1451

2017

  1. Use of Aqueous Humor and Flow Cytometry in Ocular Sarcoidosis Diagnosis

    Ocular Immunology and Inflammation, Vol. 25, Núm. 4, pp. 540-544

2011

  1. Diagnostic concordance between primary care physicians and rheumatologists in patients with work disability related to musculoskeletal disorders

    Rheumatology International, Vol. 31, Núm. 12, pp. 1549-1554

2007

  1. Lesión quística en calcáneo. Lipoma intraóseo

    Reumatologia Clinica, Vol. 3, Núm. 3, pp. 139-142

2006

  1. Consensus document of the Spanish Society of Rheumatology on the use of opioids in the treatment of rheumatic pain

    Reumatologia Clinica, Vol. 2, Núm. SPEC. ISS. 1, pp. 50-54

2003

  1. Tratamiento actual de la artritis idiopática juvenil

    Seminarios de la Fundacion Espanola de Reumatologia, Vol. 4, Núm. 4, pp. 171-189